# Diabetes Virus Detection Project, Intervention With GAD-alum

> **NCT01129232** · PHASE2 · TERMINATED · sponsor: **Oslo University Hospital** · enrollment: 6 (actual)

## Conditions studied

- Diabetes, Type I
- Enterovirus Infections
- Autoimmunity

## Interventions

- **DRUG:** GAD-alum
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01129232
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-01
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Complications to procedure
- **Last updated:** 2018-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01129232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01129232, "Diabetes Virus Detection Project, Intervention With GAD-alum". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01129232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*